Predictions
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.12
23.10.22
23.10.22
-
23.10.23
23.10.23
-24.89%
03.11.22
03.11.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.44
28.01.22
28.01.22
-
28.01.23
28.01.23
-63.05%
25.10.22
25.10.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€4.29
26.08.22
26.08.22
€6.00
26.08.23
26.08.23
-41.69%
13.10.22
13.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.18
04.09.22
04.09.22
-
04.09.23
04.09.23
-9.84%
01.10.22
01.10.22
Sienna Senior Living Inc
Start price
Target price
Perf. (%)
€9.70
19.09.22
19.09.22
€14.00
19.09.23
19.09.23
-10.31%
01.10.22
01.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
26.08.22
26.08.22
-
26.08.23
26.08.23
-4.98%
03.09.22
03.09.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.59
08.01.22
08.01.22
€9.00
08.01.23
08.01.23
-43.48%
26.08.22
26.08.22
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.40
04.10.21
04.10.21
-
04.10.22
04.10.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
11.06.22
11.06.22
€1.90
11.06.23
11.06.23
-16.96%
03.08.22
03.08.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.59
27.06.22
27.06.22
-
27.06.23
27.06.23
-27.90%
09.07.22
09.07.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
12.06.22
12.06.22
-
12.06.23
12.06.23
-26.05%
09.07.22
09.07.22
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.23
28.06.21
28.06.21
-
28.06.22
28.06.22
-24.89%
29.06.22
29.06.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.38
28.06.21
28.06.21
€2.50
28.06.22
28.06.22
-71.16%
29.06.22
29.06.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.57
16.03.22
16.03.22
€6.90
16.03.23
16.03.23
-37.18%
11.06.22
11.06.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet